SLU-PP-332 Regulatory Status As of June 2026, SLU-PP-332 is not approved by the FDA, EMA, or any other major regulator for any human indication
Novo Nordisk customer care can be reached at 800-727-6500 to address additional questions or concerns
Through secure video appointments, you can receive personalized weight loss guidance, medical evaluations, and ongoing support without the need to visit our clinic in person
Chart data sourced from 5
Tirzepatide-related dehydration combined with alcohol-related dehydration can cause significant next-day symptoms that go beyond a typical hangover
More specifically, a 2023 study in the New England Journal of Medicine evaluated the effectiveness of semaglutide in people with heart failure with preserved ejection fraction (HFpEF) and obesity